Clinical Validation of a Novel, Accelerometer Based, Continuous Respiratory Rate Sensor
1 other identifier
interventional
29
1 country
1
Brief Summary
Comparing a wireless accelerometer-based sensor that continuously measure breathing rate with the gold standard capnography. The aim is to evaluate if both methods are equivalent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedStudy Start
First participant enrolled
May 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2025
CompletedAugust 13, 2025
June 1, 2025
1 month
February 13, 2025
August 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of correctness of the sensor
The respiratory rate measured by the sensor is being compared to the respiratory rate by capnography. A discrepancy of +- 3 breaths/min is within the acceptable range.
one hour
Study Arms (1)
Adult hospitalized patients
EXPERIMENTALPatients are being monitored for one hour with a wireless, accelerometer based respiratory rate sensor and a capnograph.
Interventions
This sensor is being fasten on the chest of the patients and measures respiratory rate with the help of an accelerometer. Data is being sent wireless to a backend monitor.
Eligibility Criteria
You may qualify if:
- Admitted to the Hospital
- Expected to remain undisturbed for at least one hour
You may not qualify if:
- Not able to give informed consent
- Use of high flow oxygen therapy
- Skin disease preventing proper attachment of the sensor
- Implanted electronic medical device.
- Known infection or colonisation with microbes necessitating protective measures above routine care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eupnea ASlead
- Haraldsplass Deaconess Hospitalcollaborator
Study Sites (1)
Haraldsplass Deaconess Hospital
Bergen, 5021, Norway
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2025
First Posted
April 4, 2025
Study Start
May 16, 2025
Primary Completion
June 15, 2025
Study Completion
August 10, 2025
Last Updated
August 13, 2025
Record last verified: 2025-06